Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Small Cell Lung Carcinoma × Sorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 3 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Neoplasms 1 Liver Neoplasms 1 Carcinoma 1

Interventions

apatinib 4 Etoposide 3 surufatinib 2 Topotecan 2 Simvastatin 2 Irinotecan 2 Carboplatin 2 nintedanib 1 camrelizumab 1 anlotinib 1 Tomography, X-Ray Computed 1 Sunitinib 1 Sorafenib 1 Radiotherapy 1 Paclitaxel 1 PE regimen 1 Lithium 1 Immunotherapy 1 Ifosfamide 1 Gemcitabine 1 EC regimen 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01159327 2015-11-11

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

National Cancer Center, Korea

Phase 2 Terminated

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡